Research into Alpha-1-Antitrypsin Deficiency and Improvement of Clinical Treatment Options.
We are pleased to announce that TLRC early career clinicians Arturo Olivares-Rivera and Dr. Philipp Höger, from the Thoraxklinik Heidelberg, have been…
TLRC researcher Uwe Haberkorn is again among the most cited scientists worldwide
Seven DZL scientists are among the most cited researchers worldwide in 2023 according to the Clarivate Analytics list of "Highly Cited Researchers".…
TLRC junior scientist receives 2nd prize for scientific abstract in the field of interstitial lung diseases.
The DPLD Young Investigator Meeting took place on 17 November 2023 at the DZL-site Heidelberg.
37 young scientists had the opportunity to present…
ESTI Best Oral Presentation Award to Dr. Lena Wucherpfennig
We congratulate Dr. Lena Wucherpfennig for receiving the Best Oral Presentation Award at the annual conference of the Europoean Society for Thoracic…
Epigenetically acting drugs could support cancer immunotherapy
DZL-scientist Christoph Plass and his team have successfully used epigenetically acting drugs to increase the recognition of cancer cells by the…
![[Translate to English:]](/fileadmin/_processed_/6/b/csm_Ann_Katrin_Daum_7d7f6774b2.jpg "[Translate to English:]")
Takeda Research Award 2023 to Dr. Ann-Kathrin Daum
We are happy to announce that DZL Academy Fellow Ann-Kathrin Daum, (German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)…
ERS Educational Award 2023 to Professor Felix Herth
Professor Felix Herth received the ERS Educational Award 2023 t this year's European Respiratory Society Congress (ERS), which is the largest…
Using epigenetic profiling to identify potential COPD treatments
COPD (Chronic Obstructive Pulmonary Disease) symptoms are associated with impaired lung fibroblast function. German and British scientists have now…